We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 25, 2020

Measurable Residual Disease Associated With Survival Outcomes in Patients With Acute Myeloid Leukemia

JAMA Oncology

 

Additional Info

JAMA Oncology
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
JAMA Oncol 2020 Oct 08;[EPub Ahead of Print], NJ Short, S Zhou, C Fu, DA Berry, RB Walter, SD Freeman, CS Hourigan, X Huang, G Nogueras Gonzalez, H Hwang, X Qi, H Kantarjian, F Ravandi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading